Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT

Overview of attention for article published in Frontiers in immunology, December 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 15 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 41,677 followers.

PC | Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT https://t.co/PuH8ZcYs66

15 Jan 2022

Reply Repost Favourite

Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT https://t.co/ToI5eH0xdC

10 Jan 2022

Reply Repost Favourite

RT @FrontImmunol: New Research: Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT: Rituximab…

22 Dec 2021

Reply Repost Favourite

New Research: Case Report: Persistent Hypogammaglobulinemia More Than 10 Years After Rituximab Given Post-HSCT: Rituximab (RTX) is an anti-CD20 monoclonal antibody that targets B cells—from the immature pre-B-cell stage in the bone marrow to… https://t.co/

22 Dec 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.